Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells

Zhiguo Gao1, Yaojia Li2, Jiaqi Xing1

  • 1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, China.

Summary

This study introduces a novel mesoporous organosilica nanoscaffold (RuMSN) for selective bioorthogonal catalysis. The engineered nanoreactor enables conditional activation of prodrugs and pro-fluorophores within biological systems.